1. A case of Guillain-Barré Syndrome after atezolizumab and bevacizumab combination therapy for multiple lung metastases from hepatocellular carcinoma
   Miyu Takahashi et al, 2023, Kanzo CrossRef
2. Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms
   Aritrani Sarkar et al, 2024, Journal of the Peripheral Nervous System CrossRef
3. Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature
   Bogna N. Brzezinska et al, 2021, Gynecologic Oncology Reports CrossRef
4. Immune Checkpoint Inhibitor–related Guillain-Barré Syndrome: A Case Series and Review of the Literature
   Jorien B.E. Janssen et al, 2021, Journal of Immunotherapy CrossRef
5. Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systematic Review of 33 Cases
   Yan Li et al, 2021, BioMed Research International CrossRef
6. A Case of Acute Motor and Sensory Axonal Neuropathy Secondary to SGN-LIV1A Therapy
   Emily R Daigle et al, 2022, Cureus CrossRef
7. Immunopathological basis of immune-related adverse events induced by immune checkpoint blockade therapy
   Terufumi Kubo et al, 2022, Immunological Medicine CrossRef